13F-HR filed by Bleakley Financial Group, LLC
Bleakley Financial Group, LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-10-16, with 1,025 holding rows worth $3,281,231,734.
- Accession
- 0001936953-24-000006
- Filer
- CIK 1936953
- Filed
- 2024-10-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 1,029 entries on the cover page, a total value of $3,281,231,734 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,281,231,734 with VALUE read as dollars as filed, 13F file number 028-22837. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LUCID GROUP INC | 549498103 | COM | 13,854 | $48,905 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 22,112 | $48,204 | dollars as filed | |
| OUTDOOR HOLDING CO | 00175J107 | COMMON STOCK | 30,464 | $43,564 | dollars as filed | |
| AGILON HEALTH INC | 00857U107 | COM | 10,649 | $41,851 | dollars as filed | |
| NAVITAS SEMICONDUCTOR CORP COM | 63942X106 | Stock | 16,852 | $41,287 | dollars as filed | |
| V F CORP COM | 918204108 | Stock | 31,000 | $40,173 | dollars as filed | put |
| FATE THERAPEUTICS INC | 31189P102 | COM | 11,239 | $39,337 | dollars as filed | |
| ACCURAY INC DEL | 004397105 | COM | 19,833 | $35,699 | dollars as filed | |
| PRECIGEN INC | 74017N105 | COM | 35,220 | $33,357 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 80,000 | $32,632 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 11,116 | $31,681 | dollars as filed | |
| W & T OFFSHORE INC | 92922P106 | COM | 14,720 | $31,648 | dollars as filed | |
| SCYNEXIS INC | 811292200 | COM NEW | 20,000 | $29,800 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 16,357 | $26,989 | dollars as filed | |
| CSX Corporation | 126408103 | COM | 16,000 | $25,990 | dollars as filed | put |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 14,389 | $24,461 | dollars as filed | |
| TILRAY INC | 88688T100 | COM CL 2 | 13,016 | $22,908 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 11,404 | $20,983 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 10,791 | $18,992 | dollars as filed | |
| SHARECARE INC | 81948W104 | COM | 12,624 | $17,926 | dollars as filed | |
| I-80 GOLD CORP | 44955L106 | COM | 10,809 | $12,538 | dollars as filed | |
| TIZIANA LIFE SCIENCES LTD | G88912103 | COMMON SHARES | 10,368 | $9,953 | dollars as filed | |
| LUXURBAN HOTELS INC | 21985R105 | COM | 101,138 | $8,506 | dollars as filed | |
| PROSHARES TR | 74347G440 | BITCOIN ETF | 33,000 | $6,706 | dollars as filed | call |
| ENVIVA INC | 29415B103 | COM | 13,846 | $5,605 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001936953-24-000006 | this filing | 2024-10-16 | acceptance time not in the bulk data set |